Takeda Pharmaceutical Co Ltd (NYSE:TAK) shares gapped down prior to trading on Wednesday . The stock had previously closed at $16.84, but opened at $17.92. Takeda Pharmaceutical shares last traded at $17.93, with a volume of 73857 shares changing hands.
TAK has been the subject of a number of analyst reports. Zacks Investment Research raised Takeda Pharmaceutical from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a report on Wednesday, March 13th. Goldman Sachs Group reissued a “buy” rating on shares of Takeda Pharmaceutical in a report on Tuesday, March 19th.
The firm has a market cap of $30.45 billion, a PE ratio of 16.85, a P/E/G ratio of 67.18 and a beta of 0.66. The company has a debt-to-equity ratio of 1.19, a current ratio of 3.06 and a quick ratio of 2.81.
ILLEGAL ACTIVITY NOTICE: “Takeda Pharmaceutical (TAK) Shares Gap Down to $17.92” was originally reported by Week Herald and is owned by of Week Herald. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://weekherald.com/2019/05/15/takeda-pharmaceutical-tak-shares-gap-down-to-17-92.html.
About Takeda Pharmaceutical (NYSE:TAK)
Takeda Pharmaceutical Company Limited, together with its subsidiaries, engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. The company provides medicines in various therapeutic areas comprising gastroenterology, oncology, and neuroscience; and vaccines.
Featured Story: What does a bar chart mean for investors?
Receive News & Ratings for Takeda Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takeda Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.